Neonatal outcomes after in-utero exposure to magnesium sulphate: a retrospective analysis
Background: Magnesium sulphate (MgSO4) is routinely administered to pregnant women as a tocolytic and as a neuroprotective agent against cerebral palsy and motor impairment in preterm neonates. However, concerns have recently been arising regarding its effects in the neonate, including cardiovascula...
Main Authors: | Ricardo Barreto Mota, Vicente Rey Y Formoso, Paulo Soares, Hercília Guimarães |
---|---|
Format: | Article |
Language: | English |
Published: |
Hygeia Press di Corridori Marinella
2023-03-01
|
Series: | Journal of Pediatric and Neonatal Individualized Medicine |
Subjects: | |
Online Access: | https://jpnim.com/index.php/jpnim/article/view/1145 |
Similar Items
-
Antenatal Magnesium Sulfate, Necrotizing Enterocolitis, and Death among Neonates < 28 Weeks Gestation
by: Manijeh Kamyar, et al.
Published: (2016-03-01) -
Randomized Trial on Echocardiography-Guided Ductus Arteriosus Treatment to Reduce Necrotizing Enterocolitis
by: María Carmen Bravo, et al.
Published: (2022-01-01) -
Problemática da persistência do canal arterial: um vilão ou uma alteração presente ao acaso?
by: Marina Mafra Carvalhais, et al.
Published: (2023-06-01) -
Clinical outcomes of different patent ductus arteriosus treatment in preterm infants born between 28 and 32 weeks in Taiwan
by: Hao-Wei Chung, et al.
Published: (2023-07-01) -
MAGnesium sulphate for fetal neuroprotection to prevent Cerebral Palsy (MAG-CP)—implementation of a national guideline in Canada
by: Dane A. De Silva, et al.
Published: (2018-01-01)